Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion type Assertion NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_head.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion evidence source_evidence_literature NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion SIO_000772 14976159 NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion wasDerivedFrom befree-20140225 NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion wasGeneratedBy ECO_0000203 NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.